NCT04020068

Brief Summary

CoDiAm aims to collect clinical, biological and social data of diabetic patients in French Guiana.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 8, 2019

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 10, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 15, 2019

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 8, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 8, 2021

Completed
Last Updated

July 15, 2019

Status Verified

July 1, 2019

Enrollment Period

2 years

First QC Date

July 10, 2019

Last Update Submit

July 12, 2019

Conditions

Diabetes MellitusAdults

Keywords

DiabeteFrench Guiana

Outcome Measures

Primary Outcomes (1)

  • Improvement of patient care

    Number of health complications in diabetes mellitus ...

    2 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Diabetic patients living in French Guiana

You may qualify if:

  • Patients with diabetes
  • At least 18 years old

You may not qualify if:

  • Less than 18 years old
  • Patients under legal guardianship
  • Patients' refusal to participate
  • Patients living outside French Guiana

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier de Cayenne

Cayenne, French Guiana, 97306, France

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

blood samples

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Central Study Contacts

Nadia SABBAH, MD

CONTACT

+594594394150nadia.sabbah@ch-cayenne.fr

DRCI CAYENNE

CONTACT

+594594395385cicec@ch-cayenne.fr

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 10, 2019

First Posted

July 15, 2019

Study Start

April 8, 2019

Primary Completion

April 8, 2021

Study Completion

May 8, 2021

Last Updated

July 15, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

Locations

FR(1)